Shares of OptiNose (NASDAQ:OPTN) climbed ~61% in the premarket on Thursday after the specialty pharmaceutical company agreed to be acquired by antibiotic drugmaker Paratek Pharmaceuticals in a ...

OPTINOSE ($OPTN) posted quarterly earnings results on Wednesday, March 26th. The company reported earnings of -$0.03 per share, beating estimates of -$0.72 by $0.69 ...